Company officials at Boston Scientific discuss the company's Q4 2013 earnings call. The company reported profits of $108 million, or 8¢ per share, on sales of $1.84 billion for the 3 months ended Dec. 31, 2013, for top-line growth of 0.9% compared with Q4 2012.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1enpMaS
Cap comentari:
Publica un comentari a l'entrada